Filing Details

Accession Number:
0001192482-19-000428
Form Type:
4
Zero Holdings:
No
Publication Time:
2019-11-13 20:57:28
Reporting Period:
2019-11-08
Accepted Time:
2019-11-13 20:57:28
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1561921 Tela Bio Inc. TELA Surgical & Medical Instruments & Apparatus (3841) 455320061
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1790214 Matt Zuga C/O Highcape Partners Qp, L.p.
10751 Falls Road, Suite 300
Baltimore MD 21093
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2019-11-08 10,220 $13.00 12,675 No 4 P Indirect By HighCape Partners, L.P.
Common Stock Acquisiton 2019-11-08 75,901 $13.00 260,808 No 4 P Indirect By HighCape Partners QP, L.P.
Common Stock Acquisiton 2019-11-13 269 $0.00 12,944 No 4 C Indirect By HighCape Partners, L.P.
Common Stock Acquisiton 2019-11-13 2,931 $0.00 15,875 No 4 C Indirect By HighCape Partners, L.P.
Common Stock Acquisiton 2019-11-13 19,982 $0.00 280,790 No 4 C Indirect By HighCape Partners QP, L.P.
Common Stock Acquisiton 2019-11-13 217,816 $0.00 498,606 No 4 C Indirect By HighCape Partners QP, L.P.
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Indirect By HighCape Partners, L.P.
No 4 P Indirect By HighCape Partners QP, L.P.
No 4 C Indirect By HighCape Partners, L.P.
No 4 C Indirect By HighCape Partners, L.P.
No 4 C Indirect By HighCape Partners QP, L.P.
No 4 C Indirect By HighCape Partners QP, L.P.
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Series A Preferred Stock Disposition 2019-11-13 493,357 $0.00 19,982 $0.00
Common Stock Series A Preferred Stock Disposition 2019-11-13 6,643 $0.00 269 $0.00
Common Stock Series B Preferred Stock Disposition 2019-11-13 5,377,928 $0.00 217,816 $0.00
Common Stock Series B Preferred Stock Disposition 2019-11-13 72,417 $0.00 2,931 $0.00
Series B Preferred Stock Warrant (right to buy) Disposition 2019-11-13 123,653 $0.00 123,653 $1.16
Common Stock Warrant (right to buy) Acquisiton 2019-11-13 123,653 $0.00 5,008 $28.65
Series B Preferred Stock Warrant (right to buy) Disposition 2019-11-13 1,665 $0.00 1,665 $1.16
Common Stock Warrant (right to buy) Acquisiton 2019-11-13 1,665 $0.00 67 $28.65
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 No 4 C Indirect
0 No 4 C Indirect
0 No 4 C Indirect
0 No 4 C Indirect
0 2017-01-18 2027-01-18 No 4 C Indirect
123,653 2017-11-13 2027-01-18 No 4 C Indirect
0 2017-01-18 2027-01-18 No 4 C Indirect
1,665 2019-11-13 2027-01-18 No 4 C Indirect
Footnotes
  1. Reflects 2,455 shares of common stock received by the reporting person as a payment-in-kind dividend on Series A Preferred Stock and Series B Preferred Stock exempt from reporting under Rule 16a-9(a).
  2. Reflects 183,907 shares of common stock received by the reporting person as a payment-in-kind dividend on Series A Preferred Stock and Series B Preferred Stock exempt from reporting under Rule 16a-9(a).
  3. Shares of Series A Preferred Stock automatically converted into shares of Common Stock at a 1-for-1 conversion rate upon the closing of the Issuer's initial public offering and had no expiration date.
  4. Shares of Series B Preferred Stock automatically converted into shares of Common Stock at a 1-for-1 conversion rate upon the closing of the Issuer's initial public offering and had no expiration date.
  5. Reflects 1-for-24.69 reverse stock split which became effective on October 28, 2019.
  6. Warrants exercisable for shares of Series B Preferred Stock automatically converted into warrants exercisable for shares of Common Stock upon the closing of the Issuer's initial public offering.